Basic Information
Basic information for LINC01278-219-21aa-2
Peptide Name LINC01278-219-21aa-2
Genome Position chrX:63516910-63516945,63561049-63561075[-]
Species Human
Peptide Sequence MQLDGGDCVVWKKIQLKFARK
Peptide Length 21
Unique No (LINC01278-201-21aa,LINC01278-205-21aa-1,LINC01278-209-21aa-1,LINC01278-210-21aa,LINC01278-211-21aa,LINC01278-215-21aa,LINC01278-218-21aa,LINC01278-220-21aa,LINC01278-221-21aa,LINC01278-222-21aa,LINC01278-223-21aa,LINC01278-224-21aa,LINC01278-225-21aa,LINC01278-226-21aa-1,LINC01278-228-21aa,LINC01278-229-21aa,LINC01278-230-21aa,LINC01278-233-21aa,LINC01278-234-21aa,LINC01278-239-21aa)
Grand Average of Hydropathicity -0.3
Relative Molecular Mass 2824.28
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000662156;LINC01278-219
Transcript Length 3088
Coding Ability 0.4456
DNA Sequence Corresponding to Peptide ATGCAGTTGGATGGCGGTGACTGCGTGGTATGGAAGAAAATTCAGCTGAAATTTGCTAGAAAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :